Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Lipid Testing After Acute Myocardial Infarction

J Am Heart Assoc; ePub 2018 Jan 25; Wang, et al

Lipid testing and high-intensity statin use were infrequent after acute myocardial infarction (MI), despite previous guidelines recommendations of low-density lipoprotein cholesterol (LDL-C) goal-directed statin therapy, a recent study found. Researchers evaluated the frequency of postdischarge lipid testing and high-intensity statin use among MI patients discharged on a statin during Adult Treatment Panel third report (ATP III) guidelines era. 11,046 patients with MI aged ≥65 years were included and multivariable regression was used to evaluate the association between lipid testing and 1-year high-intensity statin use. Among the findings:

  • Only 21% of MI patients were discharged on a high-intensity statin.
  • 44% of patients discharged on a statin underwent lipid testing at 90 days.
  • Follow-up lipid testing rates were 47% among patients with in-hospital LDL-C ≥100 mg/dL and 47% among newly prescribed statin recipients.
  • By 1 year, only 14% of patients were on high-intensity statins.


Wang WT, Hellkamp A, Doll JA. Lipid testing and statin dosing after acute myocardial infarction. [Published online ahead of print January 25, 2018]. J Am Heart Assoc. doi:10.1161/JAHA.117.006460.

This Week's Must Reads

Detection & Management of Resistant Hypertension, Hypertension; ePub 2018 Sep 13; Carey, et al

Does Aspirin Prevent CV Events in Older Adults?, N Engl J Med; ePub 2018 Sep 16; McNeil, et al

Timing of ICD Placement From Last Hospitalization for HF, Circulation; ePub 2018 Sep 13; Ambrosy, et al

FFR and Quality of Life After PCI, Circulation; ePub 2018 Sep 18; Nishi, et al

VTE risk for continuous cycle oral contraceptives, Li J et al. JAMA Intern Med. 2018 Oct 1. doi:10.1001/jamainternmed.2018.4251

Must Reads in Hypercholesterolemia

Racial Differences in Statin Use, JAMA Cardiol; ePub 2018 Jun 13; Nanna, et al

LLT Use in Patients with Elevated LDL-C, Circ Cardiovasc Qual Outcomes; ePub 2018 May 10; Virani, et al

Evolocumab in Differing Patient Populations , J Pharmacokinet Pharmacodyn; ePub 2018 May 7; Kuchimanchi, et al

LDL-C Targets in Elderly Statin Users After ACS, J Am Heart Assoc; ePub 2018 May 12; Alter, et al

Patient Perspectives on Statin Therapy, Clin Cardiol; ePub 2018 May 10; Brinton